title: Familial temporal lobe epilepsy as a presenting feature of choreoacanthocytosis.
abstract: OBJECTIVE
  Choreoacanthocytosis (ChAc) is an autosomal recessive disorder caused by mutations in VPS13A on chromosome 9q21 and characterized by neurodegeneration and red cell acanthocytosis. Seizures are not uncommon in ChAc but have not been well characterized in the literature. We report two ChAc families in which patients presented with temporal lobe epilepsy.
  
  
  METHODS
  Detailed medical and family histories were obtained. EEG, video-telemetry, brain magnetic resonance imaging (MRI) with volumetric studies of amygdala and hippocampus, as well as neuropsychological testing were performed. Blood smears were examined for acanthocytosis. Mutation analysis of VPS13A was carried out in five patients.
  
  
  RESULTS
  Six patients in three sibships were initially seen with seizures. Age at seizure onset ranged from 22 to 38 years. Seizures preceded other clinical manifestations of ChAc by < or = 15 years. The epileptic aura consisted of a sensation of déjà-vu, fear, hallucinations, palpitations, or vertigo. EEG with video-telemetry showed epileptiform discharges originating either from one or both temporal lobes. Epilepsy was generally well controlled, but some patients had periods of increased seizure frequency requiring treatment with multiple antiepileptic drugs (AEDs). Both families shared a deletion of exons 70-73 of VPS13A, extending to exons 6-7 of GNA14.
  
  
  CONCLUSIONS
  Temporal lobe epilepsy may be the presenting feature of ChAc and may delay its diagnosis. Epilepsy in ChAc patients represents a challenge, because seizures may at times be difficult to control, and some AEDs may worsen the involuntary movements. Mutations in VPS13A or GNA14 or both may be associated with clinical features of temporal lobe epilepsy.
authors.affiliation: Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
authors.forename: Abdullah
authors.initials: A
authors.lastname: Al-Asmi
authors.forename: An C
authors.initials: AC
authors.lastname: Jansen
authors.forename: AmanPreet
authors.initials: A
authors.lastname: Badhwar
authors.forename: François
authors.initials: F
authors.lastname: Dubeau
authors.forename: Donatella
authors.initials: D
authors.lastname: Tampieri
authors.forename: Chaim
authors.initials: C
authors.lastname: Shustik
authors.forename: Suha
authors.initials: S
authors.lastname: Mercho
authors.forename: Ghislaine
authors.initials: G
authors.lastname: Savard
authors.forename: Carol
authors.initials: C
authors.lastname: Dobson-Stone
authors.forename: Anthony P
authors.initials: AP
authors.lastname: Monaco
authors.forename: Frederick
authors.initials: F
authors.lastname: Andermann
authors.forename: Eva
authors.initials: E
authors.lastname: Andermann
mesh_terms: D000328:Adult; D000679:Amygdala / Q000473:pathology; D000927:Anticonvulsants / Q000627:therapeutic use; D002819:Chorea / Q000175:diagnosis / Q000235:genetics*; D004569:Electroencephalography; D004833:Epilepsy, Temporal Lobe / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D005192:Family Health; D005260:Female; D006624:Hippocampus / Q000473:pathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009483:Neuropsychological Tests; D010375:Pedigree; D011379:Prognosis; D014743:Videotape Recording
chemical_list: D000927:Anticonvulsants